Several studies investigating the relationship between the circulating concentration of IGF-I and IGFBP-3 and breast cancer risk demonstrated a correlation between increasing IGF-I and IGFBP-3 levels and increased breast cancer risk, especially in pre-menopausal [8–10] and more recently also in post-menopausal women [12]. This evidence concerns the gene IGF1 and breast cancer.